Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

NCT07232290 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera (PV)

Interventions

DRUG: Flonoltinib 75mg
DRUG: Flonoltinib 100mg
DRUG: Flonoltinib 125mg
DRUG: Extended Phase Dose Group

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd